159 related articles for article (PubMed ID: 33300614)
1. Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors.
Zhu J; Li K; Yu L; Chen Y; Cai Y; Jin J; Hou T
Med Res Rev; 2021 May; 41(3):1599-1621. PubMed ID: 33300614
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation.
Zhu J; Li K; Xu L; Cai Y; Chen Y; Zhao X; Li H; Huang G; Jin J
J Adv Res; 2022 Feb; 36():1-13. PubMed ID: 35127160
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent and Selective PI3Kγ Inhibitors.
Drew SL; Thomas-Tran R; Beatty JW; Fournier J; Lawson KV; Miles DH; Mata G; Sharif EU; Yan X; Mailyan AK; Ginn E; Chen J; Wong K; Soni D; Dhanota P; Chen PY; Shaqfeh SG; Meleza C; Pham AT; Chen A; Zhao X; Banuelos J; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
J Med Chem; 2020 Oct; 63(19):11235-11257. PubMed ID: 32865410
[TBL] [Abstract][Full Text] [Related]
4. Recent discovery of phosphoinositide 3-kinase γ inhibitors for the treatment of immune diseases and cancers.
Qiu X; Tian Y; Liang Z; Sun Y; Li Z; Bian J
Future Med Chem; 2019 Aug; 11(16):2151-2169. PubMed ID: 31538525
[TBL] [Abstract][Full Text] [Related]
5. Development of PI3Kγ selective inhibitors: the strategies and application.
Gu DY; Zhang MM; Li J; Zhou YB; Sheng R
Acta Pharmacol Sin; 2024 Feb; 45(2):238-247. PubMed ID: 37803138
[TBL] [Abstract][Full Text] [Related]
6. Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
Perry MWD; Abdulai R; Mogemark M; Petersen J; Thomas MJ; Valastro B; Westin Eriksson A
J Med Chem; 2019 May; 62(10):4783-4814. PubMed ID: 30582813
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).
Mata G; Miles DH; Drew SL; Fournier J; Lawson KV; Mailyan AK; Sharif EU; Yan X; Beatty JW; Banuelos J; Chen J; Ginn E; Chen A; Gerrick KY; Pham AT; Wong K; Soni D; Dhanota P; Shaqfeh SG; Meleza C; Narasappa N; Singh H; Zhao X; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
J Med Chem; 2022 Jan; 65(2):1418-1444. PubMed ID: 34672584
[TBL] [Abstract][Full Text] [Related]
8. The role of PI3Kγ in the immune system: new insights and translational implications.
Lanahan SM; Wymann MP; Lucas CL
Nat Rev Immunol; 2022 Nov; 22(11):687-700. PubMed ID: 35322259
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
Collier PN; Martinez-Botella G; Cornebise M; Cottrell KM; Doran JD; Griffith JP; Mahajan S; Maltais F; Moody CS; Huck EP; Wang T; Aronov AM
J Med Chem; 2015 Jan; 58(1):517-21. PubMed ID: 24754609
[TBL] [Abstract][Full Text] [Related]
10. Computational study reveals substituted benzimidazole derivatives' binding selectivity to PI3Kδ and PI3Kγ.
Zhang NN; Bai X; Zhao SS; Zheng XM; Tang L; Yang SG; Zhang JQ
J Mol Model; 2022 Apr; 28(5):123. PubMed ID: 35438328
[TBL] [Abstract][Full Text] [Related]
11. A class of highly selective inhibitors bind to an active state of PI3Kγ.
Gangadhara G; Dahl G; Bohnacker T; Rae R; Gunnarsson J; Blaho S; Öster L; Lindmark H; Karabelas K; Pemberton N; Tyrchan C; Mogemark M; Wymann MP; Williams RL; Perry MWD; Papavoine T; Petersen J
Nat Chem Biol; 2019 Apr; 15(4):348-357. PubMed ID: 30718815
[TBL] [Abstract][Full Text] [Related]
12. Discovery, Optimization, and Evaluation of Potent and Highly Selective PI3Kγ-PI3Kδ Dual Inhibitors.
Jia H; Dai G; Su W; Xiao K; Weng J; Zhang Z; Wang Q; Yuan T; Shi F; Zhang Z; Chen W; Sai Y; Wang J; Li X; Cai Y; Yu J; Ren P; Venable J; Rao T; Edwards JP; Bembenek SD
J Med Chem; 2019 May; 62(10):4936-4948. PubMed ID: 31033293
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
Venable JD; Ameriks MK; Blevitt JM; Thurmond RL; Fung-Leung WP
Recent Pat Inflamm Allergy Drug Discov; 2010 Jan; 4(1):1-15. PubMed ID: 20017720
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Phosphatidylinositol 3-Kinase γ by IPI-549 Attenuates Abdominal Aortic Aneurysm Formation in Mice.
Liu R; Huang J; Ge Y; Liu S; Huang T; Cai H; Pan B; Zhang Q; Yang P; Liao M; Xu B; Wang W
Eur J Vasc Endovasc Surg; 2020 Aug; 60(2):254-263. PubMed ID: 32423743
[TBL] [Abstract][Full Text] [Related]
15. A multi-conformational virtual screening approach based on machine learning targeting PI3Kγ.
Zhu J; Jiang Y; Jia L; Xu L; Cai Y; Chen Y; Zhu N; Li H; Jin J
Mol Divers; 2021 Aug; 25(3):1271-1282. PubMed ID: 34160714
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) delta and gamma.
Ameriks MK; Venable JD
Curr Top Med Chem; 2009; 9(8):738-53. PubMed ID: 19689378
[TBL] [Abstract][Full Text] [Related]
17. Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion.
Xie Y; Abel PW; Kirui JK; Deng C; Sharma P; Wolff DW; Toews ML; Tu Y
Biochem Pharmacol; 2013 May; 85(10):1454-62. PubMed ID: 23500535
[TBL] [Abstract][Full Text] [Related]
18. In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kγ as Potential Anticancer Target.
Sharma P; Shukla A; Kalani K; Dubey V; Luqman S; Srivastava SK; Khan F
Curr Cancer Drug Targets; 2017; 17(8):722-734. PubMed ID: 28359246
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.
Ali AY; Wu X; Eissa N; Hou S; Ghia JE; Murooka TT; Banerji V; Johnston JB; Lin F; Gibson SB; Marshall AJ
Leukemia; 2018 Sep; 32(9):1958-1969. PubMed ID: 29479062
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and bioactivity evaluation of a series of quinazolinone derivatives as potent PI3Kγ antagonist.
Liang Y; Zheng Y; Yang J; Ke J; Cheng K
Bioorg Med Chem; 2023 Apr; 84():117261. PubMed ID: 37011446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
